All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F18%3A10382043" target="_blank" >RIV/00179906:_____/18:10382043 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.2147/COPD.S145573" target="_blank" >https://doi.org/10.2147/COPD.S145573</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.2147/COPD.S145573" target="_blank" >10.2147/COPD.S145573</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Inhaled therapies in patients with moderate COPD in clinical practice: current thinking

  • Original language description

    COPD is a complex, heterogeneous condition. Even in the early clinical stages, COPD carries a significant burden, with breathlessness frequently leading to a reduction in exercise capacity and changes that correlate with long-term patient outcomes and mortality. Implementation of an effective management strategy is required to reduce symptoms, preserve lung function, quality of life, and exercise capacity, and prevent exacerbations. However, current clinical practice frequently differs from published guidelines on the management of COPD. This review focuses on the current scientific evidence and expert opinion on the management of moderate COPD: the symptoms arising from moderate airflow obstruction and the burden these symptoms impose, how physical activity can improve disease outcomes, the benefits of dual bronchodilation in COPD, and the limited evidence for the benefits of inhaled corticosteroids in this disease. We emphasize the importance of maximizing bronchodilation in COPD with inhaled dual-bronchodilator treatment, enhancing patient-related outcomes, and enabling the withdrawal of inhaled corticosteroids in COPD in well-defined patient groups.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30203 - Respiratory systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    International Journal of Chronic Obstructive Pulmonary Disease [online]

  • ISSN

    1178-2005

  • e-ISSN

  • Volume of the periodical

    13

  • Issue of the periodical within the volume

    neuvedeno

  • Country of publishing house

    NZ - NEW ZEALAND

  • Number of pages

    12

  • Pages from-to

    45-56

  • UT code for WoS article

    000419078800001

  • EID of the result in the Scopus database

    2-s2.0-85038941422